Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Original Research

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study

       
Total article views   HTML views PDF downloads Totals
10,641 Dovepress* 8,577+ 1,407 9,984
PubMed Central* 2,064 368 2,432
Totals 10,641 1,775 12,416
*Since 6 December 2018

View citations on PubMed Central and Google Scholar